Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-tyrosine is a non-essential, proteinogenic amino acid that serves as a critical precursor for several physiologically important molecules, including catecholamine neurotransmitters (dopamine, norepinephrine, and epinephrine), thyroid hormones, and the pigment melanin (PubChem, CID 6057). It is synthesized endogenously from phenylalanine by the enzyme phenylalanine hydroxylase (StatPearls, Tyrosine). In clinical practice, L-tyrosine is primarily relevant in the management of metabolic disorders such as phenylketonuria (PKU), where it becomes an essential amino acid, and tyrosinemia, where its metabolic pathway is disrupted (NORD, Tyrosinemia). While not a therapeutic target in the traditional sense (like a receptor or enzyme), its levels are pharmacologically modulated, and it is used as a dietary supplement to support cognitive function under stress (NIH, Dietary Supplement Fact Sheets). Drugs like nitisinone target the enzymes involved in tyrosine catabolism to prevent the accumulation of toxic metabolites (DrugBank, DB00517). Additionally, L-tyrosine can interact with medications such as MAOIs, potentially leading to hypertensive crises, and may compete with Levodopa for transport into the central nervous system (Mayo Clinic).
L-tyrosine serves as a metabolic substrate for the synthesis of catecholamines, thyroid hormones, and melanin (PubMed, PMID 2736402). It is converted to L-DOPA by tyrosine hydroxylase, which is the rate-limiting step in the production of dopamine, norepinephrine, and epinephrine (Wikipedia, Tyrosine). Pharmacological modulation of tyrosine levels is achieved by inhibiting catabolic enzymes like 4-hydroxyphenylpyruvate dioxygenase (DrugBank, DB00517).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-tyrosine (Tyr).